Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

NEXT STORY
Bielcor Announces Free 2-Day Shipping, New N95 Masks for Sale Ahead of New Year’s Eve
PREV STORY
BioMe Inc. and Yonsei Medical Center Sign Technology Transfer Contract for Pathbreaking Microbiome Treatment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Announcing Viral Mitigation Solutions

author_avatar
NASDAQ Market News

Enzymatica AB: The board of directors in Enzymatica has resolved on a directed share issue of SEK 40.3 million

Press release Lund on August 30, 2016                                                                                          The board of directors in Enzymatica has ...

author_avatar
NASDAQ Market News

Five Prime Therapeutics to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 3

SOUTH SAN FRANCISCO, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

author_avatar
NASDAQ Market News